Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

FDA Approves the First Drug Indicated for Lipodystrophy Complications

10.03.2014 / Thomson Reuters Blog

The FDA has approved the first replacement therapy for patients with lipodystrophy, a condition so devastating and rare it has been called an “ultra orphan” disease. Myalept (metreleptin) is indicated as an adjunct to diet in patients with congenital or acquired generalized lipodystrophy, to treat complications of leptin deficiency. The drug received approval on February […]

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: